Shionogi & Co., Ltd.

4507.T
Drug Manufacturers - Specialty & Generic
2026/03/03 Updated
Market Cap: $19.4B (¥3.0T)
Stock Price: $22.74 (¥3,553)
Exchange Rate: 1 USD = ¥156.25

Stock Price Chart

2026/03/03 Updated
17.70
PER (Price Earnings Ratio)
vs Industry Avg: +8.1
2.00
PBR (Price to Book Ratio)
vs Industry Avg: +0.7
1.86%
Dividend Yield
vs Industry Avg: -1.09%

Price Trend

2026/03/03 Updated
Short-term
5-Day MA
-2.17%
Near-term
25-Day MA
+3.80%
Mid-term
75-Day MA
+19.08%
Long-term
200-Day MA
+32.90%

Price & Trading Details

2026/03/03 Updated

PRICE

Previous Close ¥3,664
Open ¥3,624
High ¥3,635
Low ¥3,528
Close ¥3,553

TRADING

Volume 2,588,000
Average Volume 2,989,654
Turnover ¥92億
Min. Purchase ¥355,300

Analyst Recommendations 9 analysts

Updated 2026/03/01
Strong Buy
0
Buy
1
1
Hold
8
8
Sell
0
Strong Sell
0
Target Price (Mean)
¥3,118
Hold
¥4,100
High
¥3,150
Median
¥2,200
Low
+15% vs Current Price
This information is based on market data from third-party data providers and is for reference only. Investment decisions are your own responsibility.

Shareholder Composition

Updated 2026/03/01
4.8%
Insider Holdings
55.6%
Institutional
39.6%
Public Float
365
Institutional Holders
Insider Holdings 4.8%
Institutional 55.6%
Public Float 39.6%

Top Mutual Funds / ETFs

Updated 2026/03/01

Major Holders

Updated 2026/03/01
Fund Name Ownership Shares Change
VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund
1.34%
11.9M +58.60%
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
1.23%
10.9M +0.18%
HARDING LOEVNER Fd.S INC-Harding Loevner Intl Eqy. PORT.
0.81%
7.2M -3.61%
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
0.78%
7.0M +2.59%
iShares Trust-iShares Core MSCI EAFE ETF
0.58%
5.2M -0.56%
Fidelity Concord Street Trust-Fidelity International Index Fund
0.30%
2.7M +1.46%
Institution Ownership Shares Change
Pacer Advisors, Inc.
0.05%
435.5K +54.26%

Dividend History 4Years Growth

Updated 2026/03/01
-%
Dividend Yield
¥66
Annual Dividend
+16.5%
YoY Growth
-%
Payout Ratio
Year Dividend Change
2025 ¥66 +16.5%
2024 ¥57 +13.3%
2023 ¥50 +25.0%
2022 ¥40 +11.1%
2021 ¥36 -

Financial Performance

2026/03/01 Updated

Revenue & Profit

Margins

Cash Flow

Financial Health

2022 2023 2024 2025
Income Statement
Revenue ¥335,138M ¥426,684M ¥435,081M ¥438,268M
Gross Profit ¥279,722M ¥364,437M ¥377,479M ¥374,441M
Operating Income ¥110,312M ¥149,004M ¥153,312M ¥156,604M
Pretax Income ¥127,109M ¥224,832M ¥204,984M ¥209,777M
Net Income ¥114,185M ¥184,965M ¥162,030M ¥170,435M
EPS ¥126.21 ¥207.03 ¥186.11 -
Operating Margin 32.92% 34.92% 35.24% 35.73%
Balance Sheet
Total Assets ¥1,150,601M ¥1,311,800M ¥1,416,918M ¥1,535,349M
Total Equity ¥975,661M ¥1,100,046M ¥1,235,325M ¥1,361,924M
Total Liabilities ¥174,940M ¥211,754M ¥181,593M ¥173,425M
Cash ¥254,420M ¥309,224M ¥358,090M ¥374,795M
Interest-bearing Debt ¥6,674M ¥9,411M ¥11,620M ¥21,882M
Equity Ratio 84.80% 83.86% 87.18% 88.70%
D/E Ratio 0.01 0.01 0.01 0.02
Cash Flow
Operating CF ¥102,068M ¥177,867M ¥154,284M ¥195,460M
Investing CF -¥96,204M -¥48,292M ¥5,922M -¥116,080M
Financing CF -¥36,615M -¥84,123M -¥126,853M -¥64,908M
Free CF ¥70,504M ¥140,680M ¥126,017M ¥143,357M
Efficiency
ROE 11.70% 16.81% 13.12% 12.51%
ROA 9.92% 14.10% 11.44% 11.10%

Latest IR Information

Latest News (5 items)

Company Information

English Name Shionogi & Co., Ltd.
Japanese Name 塩野義製薬(株)
Stock Code 4507.T (JPX)
Sector / Industry Healthcare / Drug Manufacturers - Specialty & Generic
Employees 4,955

About

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Osaka, Japan.

Data provided by Yahoo Finance